Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can patients manage their own lymphedema care better than standard compression?

NCT ID NCT07838857

Symptom relief Sponsor: Hopital Forcilles Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Head and neck lymphedema is swelling that often follows cancer treatment, causing discomfort and making daily activities harder. Standard care usually involves manual drainage, exercises, skin care, and wearing a compression garment for many hours, which some people find difficult to keep up. This trial compares that standard approach with a self-managed program that teaches patients to do their own drainage, targeted exercises, and short compression bandaging twice a day. Researchers want to see whether the self-managed approach helps people stick to their treatment during radiotherapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A self-managed rehabilitation program with self-drainage, exercises, and short compression bandaging
What this could lead to
If it works, this could offer a more practical way for people with head and neck lymphedema to manage swelling during radiotherapy, with less reliance on long-worn compression garments.
What could go wrong
The trial is small and compares two rehabilitation approaches, so it may not show a clear difference in adherence or symptom relief. Self-managed care also depends on patients being able to perform the techniques consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 56 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Histologically confirmed diagnosis of head and neck cancer * Postoperative status after surgical resection * Currently receiving adjuvant radiotherapy * No evidence of local tumor progression * Presence of head and neck lymphedema * Able to apply and remove the compression device independently or with the help of a caregiver * Clinically stable condition with no contraindication to lymphatic drainage or compression therapy * Affiliated with a social security system or beneficiary of such a system. Able to understand the study instructions * Able to follow the study procedures * Able to provide written informed consent Exclusion Criteria: * Confirmed or suspected active tumor * Confirmed or suspected local tumor recurrence * Medical contraindication to combined decongestive therapy * Acute dermatitis * Local infection * Open wound * Ongoing thrombosis * Documented primary lymphatic disease, such as congenital lymphedema * Cognitive impairment preventing understanding of the study protocol * Language barrier preventing understanding of the study protocol * Psychiatric condition preventing understanding of the study protocol * Person under legal protection guardianship or curatorship * Patient with a limitation-of-care decision.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer head and neck neoplasm Head and Neck Neoplasms lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Head and neck neoplasms Lymphedema

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.